Opendata, web and dolomites

MAPSYNE SIGNED

Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MAPSYNE project word cloud

Explore the words cloud of the MAPSYNE project. It provides you a very rough idea of what is the project "MAPSYNE" about.

disease    lateral    central    screening    envisions    brain    hardware    er    stem    als    network    trials    alzheimer    events    neuronal    phases    patch    cure    repeated    thousands    drug    technologies    cell    model    primary    microelectrode    free    more    potentials    mapping    amyotrophic    demand    aps    local    designed    clinical    suffer    preclinical    mapsyne    mini    neurons    networks    patching    cns    software    health    diseases    scales    failures    neurodegenerative    track    cultures    functional    meas    people    drugs    ec    parallel    synaptic    pluripotent    assays    clamp    dysfunction    commercialization    action    label    experiments    electrical    vitro    record    propagating    worldwide    axons    human    spatial    parkinson    automated    miniaturized    compartments    detection    aging    temporal    healthcare    million    165    https    recording    blockers    societies    cells    hd    nervous    arrays    signals    combined    discovery    sclerosis    europa    ipsc    single    combining    density    billion    proof   

Project "MAPSYNE" data sheet

The following table provides information about the project.

Coordinator
MAXWELL BIOSYSTEMS AG 

Organization address
address: ALBISRIEDERSTRASSE 253
city: ZURICH
postcode: 8047
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 187˙419 €
 EC max contribution 187˙419 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAXWELL BIOSYSTEMS AG CH (ZURICH) coordinator 187˙419.00

Map

 Project objective

More than one billion people worldwide (165 million in Europe) suffer from diseases of the central nervous system (CNS). With Europe's aging societies, the European Commission identified brain research as one of the key research areas under healthcare (https://ec.europa.eu/research/health/). Many neurodegenerative diseases are still without cure (e.g., Parkinson’s, amyotrophic lateral sclerosis (ALS) and Alzheimer’s) and repeated failures in clinical trials increase the demand for novel screening technologies to be implemented in the early phases of drug discovery.

Recent studies show that synaptic dysfunction is involved in CNS diseases. New technologies for neuronal screening targeting synaptic and network activity, combined with disease model cells in vitro, will enable novel functional assays for CNS drug discovery. This project aims to develop MAPSYNE, a Miniaturized Automated Patch-clamp SYstem combined with high-density microelectrode arrays (HD-MEAs) for multi-scale functional mapping of NEuronal networks. Patch-clamp allows detection of synaptic events and action potentials (APs) of single cells, while HD-MEAs record APs of thousands of neurons in parallel (also track APs propagating along axons). Combining the two methods will allow access to neuronal electrical signals across spatial and temporal scales.

MAPSYNE's main objectives are (1) the development of hardware and software for a fully automated mini-patching system on HD-MEAs and (2) proof-of-concept experiments using primary and human induced pluripotent stem cell (h-iPSC)-derived neuronal networks.

MAPSYNE will be designed for long-term, label-free recording of cell cultures. Other applications include local application of drugs (e.g, synaptic blockers on neuronal compartments). After this project, the ER envisions the commercialization of MAPSYNE, and eventually, its usage for preclinical CNS drug discovery.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAPSYNE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAPSYNE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MITafterVIT (2020)

Unravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseases

Read More  

InBPSOC (2020)

Increases biomass production and soil organic carbon stocks with innovative cropping systems under climate change

Read More  

E-CLIPS (2019)

Effects of Cross-Linguistic Interactions on Perception of Speech

Read More